Monjuvi Tafasitamab 200mg Injection Side Effects, Dosage & Price

 Monjuvi (tafasitamab) is a prescription medication used to treat certain types of B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL). It is given as an intravenous infusion (injection into a vein) by a healthcare professional.


The recommended dosage of Monjuvi is 12 mg/kg of body weight administered on days 1, 4, 8, 15, and 22 of a 28-day treatment cycle for a total of 6 cycles. The dosage may be adjusted based on the patient's response to the medication and any side effects.


Monjuvi works by attaching to a protein called CD19, which is found on the surface of certain types of B-cells, including those that make up DLBCL. By attaching to CD19, Monjuvi can help to destroy the cancer cells and slow down the growth of the tumor.


Common side effects of Monjuvi include fatigue, diarrhea, fever, low white blood cell count, and infections. Monjuvi can also cause serious side effects, such as infusion-related reactions, low blood pressure, and severe infections. Patients should inform their healthcare provider immediately if they experience any of these symptoms or side effects.


It is important to discuss any potential risks and benefits of Monjuvi with your healthcare provider before starting treatment. You should also inform your healthcare provider if you have a history of infections or other medical conditions, as well as any medications you are currently taking.




Comments

Popular posts from this blog

Tofacitinib Tablet 5 mg , Price & side Effects

Carfilzomib Injection 60 mg Price & Side Effects

Enhertu Injection 100 mg Price & Side Effects